Journal of Hepatology 2024
26 papers
The 2024 edition of the Journal of Hepatology highlights research centered on metabolic dysfunction-associated steatotic liver disease (MASLD) and the integration of computational tools in clinical diagnostics. A significant portion of the work focuses on refining screening methods for liver fibrosis, including the use of sequential algorithms like the ELF test and FIB-4 in populations with Type 2 Diabetes Mellitus. Notable studies also explore the development of home-based scores to detect advanced fibrosis and predict long-term liver outcomes.
Technological trends include the application of artificial intelligence and deep learning to analyze whole slide images for collagen composition and to differentiate between autoimmune hepatitis and primary biliary cholangitis. Molecular investigations address potential therapeutic targets such as Claudin-1 for biliary fibrosis and the use of RNA editing for Alpha-1 antitrypsin deficiency. Additionally, research examines cellular processes like hepatocyte polyploidisation and its role in buffering the effects of aging. Prolific contributors to this year's volume include Jakob Nikolas Kather, Rajiv Jalan, and George Boon-Bee Goh.
Top Authors
| Author | Papers |
|---|---|
| Jakob Nikolas Kather | 3 |
| Catia Perciani | 2 |
| Sai W Chung | 2 |
| Daniel Habermann | 1 |
| Dennis L. Shung | 1 |
| Dongmei Zhang | 1 |
| Fabian J Theis | 1 |
| Gary D. Bader | 1 |
| Qinghe Zeng | 1 |
| Qinghua Lu | 1 |
| Roman Goldenberg | 1 |
| Yi Jin | 1 |